Insider trading · Q3 2026 · CIK 1159036

Halozyme Therapeutics, Inc. (HALO) insider trading.

Name: Halozyme Therapeutics, Inc. insider transactions, Q3 2026
Creator: U.S. Securities and Exchange Commission

In Q3 2026, insiders at Halozyme Therapeutics, Inc. reported 37 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 27 sales worth $15.2M.

Transactions: 37
Purchases (P): 0
Sales (S): 27
Net shares, P minus S: -144,170
Insiders: 5
Last filed: 2026-09-17

Insiders

Insider	Relationship	Transactions	Sales
Torley Helen	Director, Officer · PRESIDENT AND CEO	27	20
Posard Matthew L.	Director	4	4
Connaughton Bernadette	Director	3	3
Ramsay David A	Officer · EVP, PRESIDENT, DRUG DELIVERY	2	0
Appelhans Dannielle	Director	1	0

Transactions

37 non-derivative rows, newest transaction first. Shares and prices as filed.
Date	Insider	Code	Shares	Price	Owned after	Filing
2026-09-16	Posard Matthew L.	S (D)	3,000	$106.83	71,735	Form 4
2026-09-16	Posard Matthew L.	S (D)	8,896	$108.04	62,839	Form 4
2026-09-16	Posard Matthew L.	S (D)	3,100	$106.13	74,735	Form 4
2026-09-16	Posard Matthew L.	S (D)	4,000	$108.99	58,839	Form 4
2026-09-11	Torley Helen	S (D)	4,508	$107.55	767,780	Form 4
2026-09-11	Torley Helen	S (D)	15,492	$107.15	772,288	Form 4
2026-09-11	Torley Helen	M (A)	20,000	$18.41	787,780	Form 4
2026-09-10	Torley Helen	M (A)	20,000	$18.41	787,780	Form 4
2026-09-10	Torley Helen	S (D)	14,588	$107.01	773,192	Form 4
2026-09-10	Torley Helen	S (D)	5,412	$107.58	767,780	Form 4
2026-09-09	Torley Helen	S (D)	100	$108.67	767,780	Form 4
2026-09-09	Torley Helen	S (D)	6,596	$107.82	767,880	Form 4
2026-09-09	Torley Helen	M (A)	20,000	$18.41	787,780	Form 4
2026-09-09	Torley Helen	S (D)	13,304	$107.22	774,476	Form 4
2026-09-01	Appelhans Dannielle	A (A)	1,161	$0	1,161	Form 4
2026-08-19	Torley Helen	M (A)	20,000	$18.41	787,780	Form 4
2026-08-19	Torley Helen	S (D)	7,200	$106.36	780,580	Form 4
2026-08-19	Torley Helen	S (D)	9,600	$107.22	770,980	Form 4
2026-08-19	Torley Helen	S (D)	3,200	$107.77	767,780	Form 4
2026-08-18	Torley Helen	M (A)	20,000	$18.41	787,780	Form 4
2026-08-18	Torley Helen	S (D)	5,703	$103.08	782,077	Form 4
2026-08-18	Torley Helen	S (D)	4,897	$104.11	777,180	Form 4
2026-08-18	Torley Helen	S (D)	9,400	$104.87	767,780	Form 4
2026-08-17	Torley Helen	S (D)	7,500	$103.48	767,780	Form 4
2026-08-17	Torley Helen	S (D)	9,000	$102.55	775,280	Form 4
2026-08-17	Torley Helen	S (D)	2,100	$101.77	784,280	Form 4
2026-08-17	Torley Helen	S (D)	500	$100.46	786,380	Form 4
2026-08-17	Torley Helen	M (A)	20,000	$18.41	787,780	Form 4
2026-08-17	Torley Helen	S (D)	900	$98.96	786,880	Form 4
2026-08-10	Connaughton Bernadette	S (D)	1,626	$102.8	40,418	Form 4
2026-07-08	Torley Helen	M (A)	1,923	$12.07	769,703	Form 4
2026-07-08	Torley Helen	S (D)	888	$79.28	768,815	Form 4
2026-07-08	Torley Helen	S (D)	1,035	$80.19	767,780	Form 4
2026-07-01	Connaughton Bernadette	S (D)	625	$77.21	42,044	Form 4
2026-07-01	Connaughton Bernadette	S (D)	1,000	$76.4	42,669	Form 4
2026-06-30	Ramsay David A	F (D)	5,408	$78.27	4,592	Form 4
2026-06-30	Ramsay David A	M (A)	10,000	$0	10,000	Form 4

Transaction codes in this quarter

S: 27 M: 8 A: 1 F: 1

Get HALO insider transactions through the API

Request with your API key

curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1159036&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · HALO company page · Halozyme Therapeutics, Inc. on SEC.gov

Questions

Are insiders buying or selling Halozyme Therapeutics, Inc. (HALO)?

In Q3 2026, insiders at Halozyme Therapeutics, Inc. reported 37 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 27 sales worth $15.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Halozyme Therapeutics, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/halo.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.